EVERESTOPharmaceuticals
Everest Organics Ltd — PE Ratio & Valuation Analysis
₹203.45
+2.44%
Current P/E62.05xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E1770.9x96.5% below avg
⚠️
95.3% Premium to Industry
EVERESTO P/E 62.05x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹0.17 | ₹301 | 1770.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Everest Organics Ltd Valuation
Everest Organics Ltd (EVERESTO) currently trades at 62.05x earnings. The Pharmaceuticals sector average PE is 31.77x. EVERESTO commands a premium, reflecting high growth expectations. Historically, EVERESTO has traded at an average PE of 1770.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-2.23%
Dividend Yield
0.00%
More on Everest Organics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.